NAS:GRFS (Spain)
Business Description
Grifols SA
NAICS : 325412
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan, Sant Cugat del Valles, Barcelona, ESP, 08174
Compare
Compare
Traded in other countries / regions
GRF.Austria
•
G0FB.Germany
•
GRF.Spain
•
0RDU.UK
•
GRFS.USA
Description
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and the firm's bioscience business contributed 77% of sales in 2021. Grifols also has smaller segments including diagnostics, hospital supplies, and biosupplies. Diagnostics is now roughly 15% of revenue following the Novartis and Hologic deals.
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.06 | |||||
Equity-to-Asset | 0.3 | |||||
Debt-to-Equity | 1.51 | |||||
Debt-to-EBITDA | 34.97 | |||||
Interest Coverage | 1.45 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 0.76 | |||||
Beneish M-Score | -1.62 | |||||
WACC vs ROIC |
Growth Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.4 | |||||
3-Year EBITDA Growth Rate | -8.3 | |||||
3-Year EPS without NRI Growth Rate | -31.5 | |||||
3-Year FCF Growth Rate | -13 | |||||
3-Year Book Growth Rate | 9.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Industry Rank | 39.67 | |||||
Future 3-5Y Total Revenue Growth Rate Industry Rank | 4.29 |
Momentum Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 39.35 | |||||
9-Day RSI | 35.22 | |||||
14-Day RSI | 35.34 | |||||
6-1 Month Momentum % | 0.84 | |||||
12-1 Month Momentum % | -20.94 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.68 | |||||
Quick Ratio | 0.91 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 922.62 | |||||
Days Sales Outstanding | 122.9 | |||||
Days Payable | 240.87 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -3.4 | |||||
3-Year Average Share Buyback Ratio | 0.3 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 37.46 | |||||
Operating Margin % | 12.01 | |||||
Net Margin % | 5.86 | |||||
ROE % | 1.59 | |||||
ROA % | 0.48 | |||||
ROIC % | 0.86 | |||||
ROC (Joel Greenblatt) % | 4.96 | |||||
ROCE % | 1.66 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 108.27 | |||||
Forward PE Ratio | 27.25 | |||||
PE Ratio without NRI | 108.27 | |||||
Shiller PE Ratio | 12.91 | |||||
PS Ratio | 3.85 | |||||
PB Ratio | 1.51 | |||||
Price-to-Free-Cash-Flow | 28.78 | |||||
Price-to-Operating-Cash-Flow | 17.53 | |||||
EV-to-EBIT | 54.66 | |||||
EV-to-Forward-EBIT | 18.4 | |||||
EV-to-EBITDA | 54.66 | |||||
EV-to-Forward-EBITDA | 12.38 | |||||
EV-to-Revenue | 9.68 | |||||
EV-to-Forward-Revenue | 2.76 | |||||
EV-to-FCF | 72.27 | |||||
Price-to-Projected-FCF | 0.66 | |||||
Price-to-Median-PS-Value | 1.61 | |||||
Earnings Yield (Greenblatt) % | 1.83 | |||||
Forward Rate of Return (Yacktman) % | 0.96 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:GRFS
Executives
EMBED
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1,630.971 | ||
EPS (TTM) ($) | 0.137 | ||
Beta | 0.02 | ||
Volatility % | 41.25 | ||
14-Day RSI | 35.34 | ||
14-Day ATR ($) | 0.476952 | ||
20-Day SMA ($) | 9.902 | ||
12-1 Month Momentum % | -20.94 | ||
52-Week Range ($) | 8.285 - 15.9 | ||
Shares Outstanding (Mil) | 678.91 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Grifols SA Filings
Document | Form | Filing Date | ||
---|---|---|---|---|
No Filing Data |